Macular Oedema in Uveitis : Pathogenesis, Diagnosis, and Treatment
Georg Thieme Verlag KG Stuttgart · New York..
Macular oedema is the most common cause of irreversible visual loss in patients with uveitis. The pathogenesis is caused by pro-inflammatory cytokines that lead to the breakdown of the blood-retina barrier. For the diagnosis of inflammatory macular oedema, optical coherence tomography is now mainly used, but cannot always replace fluorescein angiography. The therapy is mainly performed with intravitreally applied corticosteroids as well as systemic immunomodulators and should start as early as possible to prevent chronification of macular oedema.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:237 |
|---|---|
| Enthalten in: |
Klinische Monatsblatter fur Augenheilkunde - 237(2020), 5 vom: 01. Mai, Seite 621-626 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Makulaödem bei Uveitis: Pathogenese, Diagnostik und Therapie |
|---|
| Beteiligte Personen: |
Deuter, Christoph [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.09.2020 Date Revised 17.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1124-6732 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310165768 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310165768 | ||
| 003 | DE-627 | ||
| 005 | 20231225135510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-1124-6732 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM310165768 | ||
| 035 | |a (NLM)32434246 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Deuter, Christoph |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Macular Oedema in Uveitis |b Pathogenesis, Diagnosis, and Treatment |
| 246 | 3 | 3 | |a Makulaödem bei Uveitis: Pathogenese, Diagnostik und Therapie |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.09.2020 | ||
| 500 | |a Date Revised 17.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Georg Thieme Verlag KG Stuttgart · New York. | ||
| 520 | |a Macular oedema is the most common cause of irreversible visual loss in patients with uveitis. The pathogenesis is caused by pro-inflammatory cytokines that lead to the breakdown of the blood-retina barrier. For the diagnosis of inflammatory macular oedema, optical coherence tomography is now mainly used, but cannot always replace fluorescein angiography. The therapy is mainly performed with intravitreally applied corticosteroids as well as systemic immunomodulators and should start as early as possible to prevent chronification of macular oedema | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Grajewski, Rafael S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Klinische Monatsblatter fur Augenheilkunde |d 1963 |g 237(2020), 5 vom: 01. Mai, Seite 621-626 |w (DE-627)NLM000020109 |x 1439-3999 |7 nnns |
| 773 | 1 | 8 | |g volume:237 |g year:2020 |g number:5 |g day:01 |g month:05 |g pages:621-626 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1124-6732 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 237 |j 2020 |e 5 |b 01 |c 05 |h 621-626 | ||